BetterLife Pharma Inc. Research And Development Expense

• BetterLife Pharma Inc. showed a decrease of -25.7% in Research And Development Expense from 2024 to 2025.
• This data is from BetterLife Pharma Inc.'s annual report (Form 10-K), filed with the SEC on June 2, 2025.
• XBRL data for this metric is available from 2012 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2012 to 2025), BetterLife Pharma Inc.'s Research And Development Expense has grown by 631.1%.
• Historical annual values: Fiscal year 2025: $424.3 thousand | Fiscal year 2024: $570.9 thousand | Fiscal year 2023: $2.68 million | Fiscal year 2022: $5.42 million | Fiscal year 2021: $284.7 thousand | Fiscal year 2020: $63.8 thousand | Fiscal year 2019: $430.5 thousand | Fiscal year 2018: $90.8 thousand | Fiscal year 2012: $58.0 thousand.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026